Stock Research: Kissei Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Kissei Pharmaceutical

TSE:4547 JP3240600001
46
  • Value
    80
  • Growth
    14
  • Safety
    Safety
    94
  • Combined
    80
  • Sentiment
    4
  • 360° View
    360° View
    46
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceutical products. Its main businesses include the collection and analysis of medicine development information, manufacture and sale of medicines, purchase and sale of related materials, system development, construction contract work, facility management, and insurance agency business. It primarily operates in Japan. In the last fiscal year, the company had 1778 employees, a market cap of $1308 million, profits of $294 million, and revenue of $589 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
80 76 86 85
Growth
14 51 35 19
Safety
Safety
94 92 65 94
Sentiment
4 32 10 44
360° View
360° View
46 81 45 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
43 17 35 78
Opinions Change
21 28 6 96
Pro Holdings
n/a 80 44 12
Market Pulse
7 44 7 3
Sentiment
4 32 10 44
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
80 76 86 85
Growth
14 51 35 19
Safety Safety
94 92 65 94
Combined
80 98 77 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
64 56 86 47
Price vs. Earnings (P/E)
41 48 55 72
Price vs. Book (P/B)
90 95 78 100
Dividend Yield
79 63 78 88
Value
80 76 86 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
9 11 33 67
Profit Growth
24 32 42 11
Capital Growth
12 82 7 1
Stock Returns
84 78 87 71
Growth
14 51 35 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
89 91 85 82
Refinancing
76 83 89 91
Liquidity
84 76 4 61
Safety Safety
94 92 65 94

Similar Stocks

Discover high‑ranked alternatives to Kissei Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Starts

TSE:8850
Country: Japan
Industry: Real Estate: Diversified Operations
Size: Medium
Full Stock Analysis

Kyudenko

TSE:1959
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Kumagai Gumi

TSE:1861
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: